Morgan Stanley’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-98,686
| Closed | -$18.8K | – | 7847 |
|
|
2023
Q2 | $18.8K | Hold |
98,686
| – | – | ﹤0.01% | 6590 |
|
|
2023
Q1 | $33.6K | Buy |
98,686
+1,068
| +1% | +$363 | ﹤0.01% | 6431 |
|
|
2022
Q4 | $31.6K | Buy |
97,618
+1,049
| +1% | +$339 | ﹤0.01% | 6488 |
|
|
2022
Q3 | $40K | Buy |
96,569
+30,149
| +45% | +$12.5K | ﹤0.01% | 6509 |
|
|
2022
Q2 | $28K | Sell |
66,420
-1,854
| -3% | -$782 | ﹤0.01% | 6861 |
|
|
2022
Q1 | $86K | Buy |
68,274
+1,174
| +2% | +$1.48K | ﹤0.01% | 6411 |
|
|
2021
Q4 | $87K | Sell |
67,100
-3,517
| -5% | -$4.56K | ﹤0.01% | 6524 |
|
|
2021
Q3 | $145K | Sell |
70,617
-5,622
| -7% | -$11.5K | ﹤0.01% | 6173 |
|
|
2021
Q2 | $120K | Buy |
76,239
+10,471
| +16% | +$16.5K | ﹤0.01% | 6273 |
|
|
2021
Q1 | $146K | Sell |
65,768
-35,979
| -35% | -$79.9K | ﹤0.01% | 5828 |
|
|
2020
Q4 | $253K | Buy |
101,747
+27,596
| +37% | +$68.6K | ﹤0.01% | 5472 |
|
|
2020
Q3 | $182K | Sell |
74,151
-4,045
| -5% | -$9.93K | ﹤0.01% | 5166 |
|
|
2020
Q2 | $277K | Buy |
78,196
+6,500
| +9% | +$23K | ﹤0.01% | 4915 |
|
|
2020
Q1 | $168K | Buy |
71,696
+1,309
| +2% | +$3.07K | ﹤0.01% | 4946 |
|
|
2019
Q4 | $155K | Buy |
70,387
+1,562
| +2% | +$3.44K | ﹤0.01% | 5505 |
|
|
2019
Q3 | $126K | Sell |
68,825
-41,869
| -38% | -$76.7K | ﹤0.01% | 5358 |
|
|
2019
Q2 | $160K | Buy |
110,694
+27,160
| +33% | +$39.3K | ﹤0.01% | 5120 |
|
|
2019
Q1 | $165K | Sell |
83,534
-63,600
| -43% | -$126K | ﹤0.01% | 5163 |
|
|
2018
Q4 | $193K | Sell |
147,134
-2,984
| -2% | -$3.91K | ﹤0.01% | 5299 |
|
|
2018
Q3 | $369K | Sell |
150,118
-5,973
| -4% | -$14.7K | ﹤0.01% | 5153 |
|
|
2018
Q2 | $524K | Buy |
156,091
+38,776
| +33% | +$130K | ﹤0.01% | 5068 |
|
|
2018
Q1 | $496K | Buy |
117,315
+4,987
| +4% | +$21.1K | ﹤0.01% | 5006 |
|
|
2017
Q4 | $370K | Buy |
112,328
+25,037
| +29% | +$82.5K | ﹤0.01% | 5137 |
|
|
2017
Q3 | $333K | Sell |
87,291
-144,681
| -62% | -$552K | ﹤0.01% | 5107 |
|
|
2017
Q2 | $1.02M | Buy |
231,972
+192,576
| +489% | +$847K | ﹤0.01% | 4365 |
|
|
2017
Q1 | $144K | Buy |
39,396
+30,749
| +356% | +$112K | ﹤0.01% | 5470 |
|
|
2016
Q4 | $24K | Sell |
8,647
-19,629
| -69% | -$54.5K | ﹤0.01% | 5958 |
|
|
2016
Q3 | $93K | Buy |
28,276
+21,762
| +334% | +$71.6K | ﹤0.01% | 5341 |
|
|
2016
Q2 | $22K | Sell |
6,514
-3,527
| -35% | -$11.9K | ﹤0.01% | 5820 |
|
|
2016
Q1 | $25K | Sell |
10,041
-308,708
| -97% | -$769K | ﹤0.01% | 5856 |
|
|
2015
Q4 | $1.05M | Sell |
318,749
-226,932
| -42% | -$744K | ﹤0.01% | 4015 |
|
|
2015
Q3 | $1.88M | Buy |
545,681
+538,172
| +7,167% | +$1.85M | ﹤0.01% | 3572 |
|
|
2015
Q2 | $10K | Buy |
7,509
+6,940
| +1,220% | +$9.24K | ﹤0.01% | 6300 |
|
|
2015
Q1 | $0 | Sell |
569
-3,621
| -86% | – | ﹤0.01% | 6693 |
|
|
2014
Q4 | $1K | Sell |
4,190
-19,190
| -82% | -$4.58K | ﹤0.01% | 6506 |
|
|
2014
Q3 | $101K | Sell |
23,380
-8,712
| -27% | -$37.6K | ﹤0.01% | 5478 |
|
|
2014
Q2 | $159K | Buy |
32,092
+16,478
| +106% | +$81.6K | ﹤0.01% | 5270 |
|
|
2014
Q1 | $86K | Buy |
15,614
+7,427
| +91% | +$40.9K | ﹤0.01% | 5511 |
|
|
2013
Q4 | $50K | Sell |
8,187
-1,912
| -19% | -$11.7K | ﹤0.01% | 5591 |
|
|
2013
Q3 | $67K | Buy |
+10,099
| New | +$67K | ﹤0.01% | 5160 |
|